文献速递系统性红斑狼疮

生物标志物组合在预测系统性红斑狼疮肾脏复发方面可能优于单一分子:一项探索性研究

Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该探索性研究纳入61例前瞻性随访的SLE患者,在8个月随访期间8例发生肾脏复发。基线尿L-PGDS、ICAM-1和VCAM-1水平在后续复发者中显著升高,Cox回归显示这些标志物及低补体血症、抗dsDNA抗体与肾脏复发相关,ROC分析提示新型联合传统标志物的组合能准确识别复发。

要点

  • 基线尿L-PGDS、ICAM-1和VCAM-1在后续肾脏复发SLE患者中显著升高。
  • Cox回归显示L-PGDS、ICAM-1、VCAM-1、低补体血症和抗dsDNA抗体与肾脏复发相关。
  • 新型联合传统标志物的组合在ROC分析中表现出准确识别肾脏复发的能力。

核心结论

  • 本研究提示新型生物标志物组合可能有助于预测SLE患者的肾脏复发。

研究设计与样本

  • 前瞻性随访的SLE患者队列,共收集61例患者尿液样本,采用ELISA测定尿生物标志物水平,随访8个月。

主要发现

  • 8个月随访期间8例患者发生肾脏复发,其余53例未复发。
  • 后续发生肾脏复发患者的尿L-PGDS、ICAM-1和VCAM-1水平较未复发者显著升高。
  • Cox回归分析中,L-PGDS、ICAM-1、VCAM-1、低补体血症和抗dsDNA抗体是与肾脏复发相关的因素。
  • 基于ROC分析,新型与传统生物标志物的组合表现出准确识别肾脏复发的优异能力。

关键数值与推荐

  • 尿生物标志物采用ELISA法测定。
  • 组间比较采用非配对Student t检验或Mann-Whitney U检验。
  • 采用ROC分析计算曲线下面积,采用Cox回归识别与疾病复发相关的独立因素。

临床怎么用

  • 对于SLE患者,可考虑联合检测尿L-PGDS、ICAM-1、VCAM-1及传统标志物(低补体血症、抗dsDNA抗体)以辅助评估肾脏复发风险。

局限性

  • 本研究为探索性研究,样本量较小(61例),随访期间肾脏复发事件少(8例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent evidence suggests that some urinary biomarkers, namely Vascular Cell Adhesion Molecule-1 (VCAM-1), Intercellular Adhesion Molecule-1 (ICAM-1), Monocyte Chemoattractant Protein 1 (MCP-1), Neutrophil Gelatinase Associated Lipocalcin and Lipocalin-type Prostaglandin D-Synthetase (L-PGDS), might discriminate SLE patients with ongoing renal activity from those with stable disease. The objective of this study was to assess the role of these markers in predicting renal flares in comparison with conventional biomarkers and to derive a biomarker panel which may improve diagnostic accuracy. METHODS: Eligible participants were SLE patients prospectively followed at our clinic. Urinary biomarker levels were measured in urinary sample by ELISA assay and were compared by the unpaired Student's t test or the Mann-Whitney U test as appropriate. Receiver operating characteristic analysis was used to calculate the area under the curve. Cox regression was used to identify independent factors associated with disease flares. RESULTS: Urine was collected from 61 patients. During 8 months' follow-up, eight patients experienced a renal flare. Urinary L-PGDS, ICAM-1 and VCAM-1 levels were significantly increased in the patients who subsequently experienced a renal flare with respect to the remaining 53. At Cox regression analysis, L-PGDS, ICAM-1, VCAM-1, hypocomplementemia and anti-dsDNA antibodies were factors associated with renal flares. Based on receiver operating characteristic analysis, a combination of novel and conventional biomarkers demonstrated an excellent ability for accurately identifying a flare. CONCLUSION: This study might suggest the usefulness of a novel biomarker panel in predicting a renal flare in SLE.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Fasano S, Pierro L, Borgia A, et al. Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study. Rheumatology (Oxford). 2020. PMID: 32211780. doi:10.1093/rheumatology/keaa074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。